Investigating how enzymes activate and inhibit their functions
Studies on Enzyme Activation and Novel Modes of Inhibition
This study is looking at how certain enzymes, which help speed up chemical reactions in the body, change shape to do their job better, and by understanding this, researchers hope to create new medicines that can help people by targeting these enzymes more effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-10754934 on NIH RePORTER |
What this research studies
This research explores the mechanisms by which enzymes achieve specificity in binding to their transition states, which is crucial for their catalytic activity. The team at the University of Buffalo is examining specific enzymes like triosephosphate isomerase and orotidine 5'-monophosphate decarboxylase to understand how they change shape to become active. By identifying the binding interactions that trigger these conformational changes, the research aims to develop novel inhibitors for these enzymes, potentially leading to new therapeutic options. Patients may benefit from insights gained in this research that could inform drug design targeting specific enzyme functions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to enzyme dysfunction or those requiring targeted enzyme inhibitors.
Not a fit: Patients with conditions unrelated to enzyme activity or those not requiring enzyme-targeted therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new drugs that more effectively target specific enzymes involved in various diseases.
How similar studies have performed: Previous research has shown success in understanding enzyme mechanisms and developing inhibitors, suggesting that this approach has potential for meaningful advancements.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Richard, John P — State University of New York at Buffalo
- Study coordinator: Richard, John P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.